Research Catalog

Details

Additional authors

1. Center for Biologics Evaluation and Research (U.S.)
2. Center for Drug Evaluation and Research (U.S.)

Description

1. 1 online resource (i, 4 pages)

Alternative title

1. Independent consultants for biotechnology clinical trial protocols

Subject

1. Consultants > Government policy > United States
2. Clinical trials > Government policy > United States
3. Medical protocols > Government policy > United States

Call number

1. GPO Internet HE 20.4802:IN 2/2

Note

1. Title from title screen (viewed on May 22, 2009).
2. "August 2004".

System details (note)

1. Mode of access: Internet at the FDA CBER web site. Address as of 5/22/09: http://www.fda.gov/cber/gdlns/bioclin.pdf ; current access is available via PURL.

Title

1. Guidance for industry : independent consultants for biotechnology clinical trial protocols.

Publisher

1. Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research : Center for Drug Evaluation and Research, [2004]

Type of content

1. text

Type of medium

1. computer

Type of carrier

1. online resource

System details

1. Mode of access: Internet at the FDA CBER web site. Address as of 5/22/09: http://www.fda.gov/cber/gdlns/bioclin.pdf ; current access is available via PURL.

Connect to:

1. https://purl.fdlp.gov/GPO/LPS112997

Added author

1. Center for Biologics Evaluation and Research (U.S.)
2. Center for Drug Evaluation and Research (U.S.)

Gpo item no.

1. 0499-T-02 (online)

Sudoc no.

1. HE 20.4802:IN 2/2